MYRIAD GENETICS INC Quarterly Marketable Securities, Current in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Myriad Genetics Inc quarterly Marketable Securities, Current history and growth rate from Q2 2010 to Q2 2024.
  • Myriad Genetics Inc Marketable Securities, Current for the quarter ending June 30, 2024 was $4.9M, a 73.9% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.9M -$13.9M -73.9% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $7.4M -$17.7M -70.5% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $8.8M -$49.2M -84.8% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $10.3M -$72.2M -87.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $18.8M -$81.1M -81.2% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $25.1M -$78.1M -75.7% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $58M -$23.4M -28.7% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $82.5M +$11.6M +16.4% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $99.9M +$53.9M +117% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $103M +$76M +279% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $81.4M +$47.7M +142% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $70.9M +$28.8M +68.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $46M -$8.1M -15% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $27.2M -$33.3M -55% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $33.7M -$26.7M -44.2% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $42.1M -$10.6M -20.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $54.1M +$10.4M +23.8% Jun 30, 2020 10-KT 2021-03-16
Q1 2020 $60.5M -$4.3M -6.64% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $60.4M -$14.4M -19.3% Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $52.7M -$21.5M -29% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $43.7M -$26M -37.3% Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $64.8M +$4.9M +8.18% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $74.8M +$20M +36.5% Dec 31, 2018 10-Q 2019-02-06
Q3 2018 $74.2M +$13.8M +22.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $69.7M +$21.4M +44.3% Jun 30, 2018 10-K 2019-08-13
Q1 2018 $59.9M +$11.6M +24% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $54.8M +$400K +0.74% Dec 31, 2017 10-Q 2018-02-07
Q3 2017 $60.4M -$1.1M -1.79% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $48.3M -$42.2M -46.6% Jun 30, 2017 10-K 2018-08-24
Q1 2017 $48.3M -$47.9M -49.8% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $54.4M -$30.2M -35.7% Dec 31, 2016 10-Q 2017-02-08
Q3 2016 $61.5M -$6.5M -9.56% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $90.5M +$9.8M +12.1% Jun 30, 2016 10-K 2017-08-09
Q1 2016 $96.2M +$17M +21.4% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $84.6M -$20.8M -19.7% Dec 31, 2015 10-Q 2016-02-03
Q3 2015 $68M -$21.8M -24.3% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $80.7M -$40.9M -33.6% Jun 30, 2015 10-K 2016-08-10
Q1 2015 $79.2M -$47.1M -37.3% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $105M -$177M -62.6% Dec 31, 2014 10-Q 2015-02-04
Q3 2014 $89.8M -$182M -67% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $122M -$147M -54.7% Jun 30, 2014 10-K 2015-08-12
Q1 2014 $126M -$97.5M -43.5% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $282M -$8.21M -2.83% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $272M +$18.4M +7.28% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $268M +$14.1M +5.53% Jun 30, 2013 10-K 2014-08-13
Q1 2013 $224M -$8.68M -3.73% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $290M +$48.4M +20% Dec 31, 2012 10-Q 2013-02-06
Q3 2012 $254M -$33.3M -11.6% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $254M -$39.6M -13.5% Jun 30, 2012 10-K 2013-08-14
Q1 2012 $233M -$61.3M -20.9% Mar 31, 2012 10-Q 2012-05-02
Q4 2011 $242M -$81.8M -25.3% Dec 31, 2011 10-Q 2012-02-01
Q3 2011 $287M -$18.2M -5.96% Sep 30, 2011 10-Q 2011-11-02
Q2 2011 $294M -$16.6M -5.35% Jun 30, 2011 10-K 2012-08-15
Q1 2011 $294M Mar 31, 2011 10-Q 2011-05-04
Q4 2010 $324M Dec 31, 2010 10-Q 2011-02-01
Q3 2010 $305M Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $310M Jun 30, 2010 10-K 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.